HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
BronchogenHPLC ≥ 99%MS confirmed20mg
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | Bronchogen |
|---|---|
| Molecular formula | C18H30N4O9 |
| Molecular weight | 446.5 g/mol |
| Sequence | H-Ala-Glu-Asp-Leu-OH |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 20mg |
| Documentation | Batch-linked COA + HPLC chromatogram + MS identity record for every production lot |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder at -20°C, protected from light and moisture; brief room-temperature transit is tolerated. After reconstitution (bacteriostatic water recommended), store at 2-8°C and use within the validated stability window. Avoid repeated freeze-thaw cycles. |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| OEM lot | 50 kits (500 vials) | 3–7 days |
| Production lot | 500–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Supplied as a research-use peptide. Every quote confirms current-batch COA, purity, destination market and buyer track before invoicing.
Overview
About Bronchogen.
Bronchogen is an ultrashort peptide bioregulator (a tetrapeptide, sequence Ala-Glu-Asp-Leu) belonging to the Khavinson family of tissue-specific "cytogen" peptides. Preclinical and in vitro studies describe it interacting with DNA and modulating gene expression in bronchial epithelial and pulmonary cell models; it is supplied strictly as a research-use reference material.
Documentation
Batch documentation support for Bronchogen lots.
batch-linked COA, HPLC chromatogram and MS identity record for every production lot. Distribution scope confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the Bronchogen reference profile.
Lot traceability
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
Bronchogen — frequently asked by B2B buyers.
What format and vial size does Pepti supply Bronchogen in?
Bronchogen is supplied as a sterile-filtered, lyophilized white powder in 20 mg vials sealed under inert conditions. The minimum order quantity is 50 kits (500 vials); larger bulk quantities and boxed kit configurations are available on request.
What documentation ships with each batch?
Every batch is released with a Certificate of Analysis reporting HPLC purity and identity confirmation by mass spectrometry (MS). Supplementary reports such as water content, residual solvents, or independent third-party testing can be provided on request for qualified B2B accounts.
Does Bronchogen have a CAS number?
No CAS Registry Number is currently assigned to Bronchogen. It is identified by its tetrapeptide sequence (Ala-Glu-Asp-Leu), molecular formula C18H30N4O9, and molecular weight of approximately 446.5 g/mol, and we confirm identity per batch by MS rather than by CAS.
Can Pepti provide private-label or custom OEM packaging?
Yes. We offer OEM and private-label services including custom fill weights, vial labeling, boxed kits, and branded documentation. Artwork requirements, lead times, and specifications are confirmed at the quotation stage.
Is Bronchogen sold for therapeutic or consumer use?
No. Bronchogen is supplied strictly as a research-use-only reference material for laboratory and manufacturing customers. It is not a medicine, supplement, or food, and Pepti provides no dosing or use guidance. Buyers are responsible for regulatory compliance in their destination market.
Related compounds